Hostname: page-component-54dcc4c588-dbm8p Total loading time: 0 Render date: 2025-10-12T15:04:35.896Z Has data issue: false hasContentIssue false
  • English
  • Français

Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2

Published online by Cambridge University Press:  14 March 2024

Masataka Nakagawa ,
Yumiko Fujishiro ,
Yohei Doi ,
Junichi Yamakami  and
Hitoshi Honda Open the ORCID record for Hitoshi Honda [Opens in a new window]
Masataka Nakagawa
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Yumiko Fujishiro
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Yohei Doi
Affiliation:
Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Junichi Yamakami
Affiliation:
Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Hitoshi Honda*
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan
*
Corresponding author: Hitoshi Honda; Email: hitoshihonda@fujita-hu.ac.jp
Get access Rights & Permissions [Opens in a new window]

Abstract

We evaluated the secondary COVID-19 incidence among uninfected hospitalized patients after nosocomial COVID-19 exposure. An exposure source of SARS-CoV-2 was hospitalized patients or healthcare personnel (HCP) newly diagnosed as having COVID-19. Patients exposed to a COVID-19-infected patient in a shared room more frequently developed COVID-19 than those exposed to an infected HCP.

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 45 , Issue 7 , July 2024 , pp. 903 - 905
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069.10.1001/jama.2020.1585CrossRefGoogle ScholarPubMed
Klompas, M, Baker, MA, Rhee, C. Is nosocomial SARS-CoV-2 still worth preventing? JAMA Netw Open 2023;6:e2344704.10.1001/jamanetworkopen.2023.44704CrossRefGoogle ScholarPubMed
Moderna, Inc. Realtime epidemiology data for COVID-19, influenza, and RS virus. 2024. https://moderna-epi-report.jp. Accessed February 13, 2024.Google Scholar
Honda, H, Nakagawa, M, Nisida, R, et al. Discontinuation of admission screening for coronavirus disease 2019 (COVID-19) and the impact on in-hospital clusters of COVID-19: Experience at a tertiary-care center. Infect Control Hosp Epidemiol 2023;44:1877–1880.10.1017/ice.2023.66CrossRefGoogle ScholarPubMed
Center for Disease Control and Prevention. Interim guidance for managing healthcare personnel with SARS-CoV-2 infection or exposure to SARS-CoV-2. 2022. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html Google Scholar
Lindsley, WG, Derk, RC, Coyle, JP, et al. Efficacy of portable air cleaners and masking for reducing indoor exposure to simulated exhaled SARS-CoV-2 aerosols - United States, 2021. MMWR Morb Mortal Wkly Rep 2021;70:972–976.10.15585/mmwr.mm7027e1CrossRefGoogle ScholarPubMed
Oran, DP, Topol, EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med 2021;174:655–662.10.7326/M20-6976CrossRefGoogle ScholarPubMed